• About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.
Heart Valve Voice USHeart Valve Voice US
  • About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.

Comment on CMS Coverage Policy for Transcatheter Tricuspid Valve Repair – TTVR

Home Policy CenterComment LetterComment on CMS Coverage Policy for Transcatheter Tricuspid Valve Repair – TTVR

Comment on CMS Coverage Policy for Transcatheter Tricuspid Valve Repair – TTVR

July 24, 2024 Comment Letter, Policy Center

Dear Administrator Brooks-LaSure,

As members of the Heart Valve Disease Policy Task Force, a national group of 30 leaders including clinician and patient advocates, we appreciate the opportunity to comment on the NCD Tracking Sheet regarding the Transcatheter Tricuspid Valve Replacement (TTVR) and want to emphasize the critical importance of establishing a comprehensive Medicare coverage policy that includes all FDA-approved minimally invasive transcatheter devices to improve quality of life and functional status in patients with symptomatic severe tricuspid regurgitation (TR) despite optimal medical therapy. Such a policy is not only pivotal in addressing the unmet needs of Medicare beneficiaries suffering from tricuspid regurgitation but also in facilitating timely access to innovative and life-saving technologies.

Read full comment letter here.

Share
0

You also might be interested in

Heart Valve Voice US Announces Major Initiatives for Valve Disease Day Including My Valve My Voice Community App, Caregiver Event

Feb 15, 2022

WASHINGTON, DC – February 15, 2022 – Heart Valve Voice[...]

CMS Decision on TAVR Puts Patients at the End of the Line

Jun 24, 2019

The Centers for Medicaid and Medicare Services today issued their[...]

Robyn Peacock

Robyn Peacock

Aug 6, 2024

Can you share your experience with heart valve disease? In[...]

Contact Us

Please contact us with any questions or to get involved.

Send Message
Join the My Valve My Voice patient community Download the app
Sign Up for Our Mailing List
  • facebook
  • x
  • linkedin

© · Heart Valve Voice

Terms of Use
Privacy Policy

Website Management provided by Genacom

Contact Info

  • Heart Valve Voice US
  • 100 M Street SE 600 Washington, DC 20003
  • info@heartvalvevoice-us.org
  • https://www.heartvalvevoice-us.org
Prev Next